检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张克勤[1] 张辉[1] 孙鼎琪[1] 傅强[1] Zhang Keqin;Zhang Hui;Sun Dingqi;Fu Qiang(Department of urology,shandong Provincial Hospital,Jinan 250021,China)
机构地区:[1]山东大学附属省立医院泌尿外科
出 处:《中国男科学杂志》2019年第2期58-61,共4页Chinese Journal of Andrology
摘 要:目的评价宁泌泰胶囊治疗慢性附睾炎的临床疗效。方法采用自身对照的临床研究方法,筛选入组40例慢性附睾炎患者,受试者口服宁泌泰胶囊,4粒/次,3次/d,连续服用4周。以CESI评分、附睾结节大小为主要疗效指标,评价宁泌泰胶囊的临床疗效。结果症状评分结果显示,治疗前CESI评分为(14.53±2.97),治疗2周和治疗4周后分别下降至(13.33±3.22)和(10.72±3.49),治疗后与治疗前比较,差异均具统计学意义(M0.0001);疼痛评分治疗前为(6.28±1.78),治疗2周和治疗4周后分别为(5.50±1.95)和(4.49±1.73),治疗后与治疗前比较,差异均具统计学意义;生活质量评分治疗前为(8.25±1.58),治疗2周和治疗4周后分别为(7.82±1.69)和(6.23±2.16),治疗2周和4周后与治疗前比较差异均有统计学意义(P<0.01,20.0001)。彩色多普勒超声结果显示,治疗前附睾三径线平均值为(1.30±0.20),治疗4周后降至(0.84±0.32),治疗前后比较差异具统计学意义(P<0.0001 )o治疗4周总有效率为79.49%。结论宁泌泰胶囊能显著改善慢性附睾炎患者的CESI评分和附睾结节大小,具有良好的疗效。Objective To evaluate the clinical efficacy of Ningmitai Capsule in the treatment of chronic epididymitis. Methods A total of 40 patients with chronic epididymitis were included in this self-control clinical trial. The subjects were treated with Ningmitai Capsule orally at the dose of 4 capsules per time, three times a day for 4 weeks. The CESI score and epididymal nodule size, as the main therapeutic index, were examined to evaluate the clinical effectiveness. Results The CESI total score was 14.53±2.97 before treatment, and decreased to 13.33±3.222 (P<0.0001) and 10.72±3.486 (P<0.0001) respectively after 2 and 4 weeks of treatment. The pain score decreased from 6.275±1.783 to 5.5± 1.948 (P<0.0001) and 4.487+ 1.73 (P<0.0001) after 2 and 4 weeks of treatment. The quality of life score decreased from 8.25±1.581 to 7.825±1.693 (P<0.01) and 6.231 ±2.158 (P<0.0001) after 2 and 4 weeks of treatment. The Color Doppler ultrasound data showed that the mean diameter of epididymis was 1.295+0.2008 before treatment, and decreased to 0.8387±0.3197 after 4 weeks of treatment (P< 0.0001). After treatment for 4 weeks, the total therapeutic efficiency rate was 79.49%. Conclusion Ningmitai capsule can significantly improve the CESI score and epididymal nodule size in patients with chronic epididymitis, and has good efficacy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117